Two Product Categories
Contraceptive litigation divides between devices and hormonal products. Device claims involve intrauterine devices and implants, alleging migration from position, perforation of the uterine wall, breakage during removal, or difficulty locating an implant.
Hormonal product claims involve pills, injections, patches and rings, and typically allege that risks such as blood clots, or effects associated with long-term use, were not adequately conveyed.
All contraception carries known risks
Every method has documented adverse effects appearing in approved labelling. Litigation concerns whether a specific risk was adequately disclosed or was understated relative to what the manufacturer knew, not whether risk existed at all.
The Legal Framework
Failure to warn is the principal theory, assessed in most states under the learned intermediary doctrine, so adequacy is judged by what the prescribing clinician was told in professional labelling.
Design defect claims argue a safer feasible alternative existed. For devices with full premarket approval, federal preemption can bar state law claims entirely, leaving only parallel claims alleging violation of the federal requirements themselves.
That preemption distinction means the regulatory pathway a product followed can determine whether any claim exists, independent of the underlying medical facts.
What Patients Should Document
Obtain the insertion and removal records for a device, including product identification and lot number, plus any imaging locating a migrated device and operative reports for retrieval procedures.
For hormonal products, pharmacy dispensing records establish which product, manufacturer and dates, which matters because brand and generic manufacturers are in different legal positions.
Do not stop contraception to pursue a claim
Stopping without an alternative carries its own consequences, and any change belongs to you and your clinician. Pursuing a claim never requires discontinuing a method, and doing so on legal rather than medical advice is not appropriate.
Free Legal Evaluation
Do You Qualify to File a Claim?
Our network of verified plaintiff attorneys offers free, no-obligation case evaluations. Contingency fee representation means you pay nothing unless you win.
Contraceptive Lawsuits: Device Migration, Hormonal Risks and Warning Claims: Frequently Asked Questions
Answers to the most common questions about this case and your legal options.
What do contraceptive lawsuits allege?
For devices, migration, perforation or breakage. For hormonal products, that risks such as blood clots or long-term effects were not adequately conveyed.
Does every side effect support a claim?
No. All methods have documented risks in approved labelling. Claims concern whether a specific risk was adequately disclosed relative to what was known.
What is the learned intermediary doctrine?
A rule under which the duty to warn runs to the prescribing clinician, so warning adequacy is judged by professional labelling rather than patient leaflets.
Why does preemption matter for devices?
Devices with full premarket approval attract federal preemption of state law claims, which can bar a case regardless of the medical facts.
What records should I obtain?
Insertion and removal records with product and lot identification, imaging and operative reports for devices, and pharmacy dispensing records for hormonal products.
Legal Disclaimer
This article is general legal information, not legal advice, and does not create an attorney-client relationship. Case status, eligibility criteria, and any amounts described are as reported at the date shown and may change. Consult a licensed attorney in your jurisdiction about your own situation.